全球□治疗市场：按产品类型、应用、给药途径、地区 - 规模、份额、展望、机会分析，2023-2030 年

由于新的製造、修饰和分析技术，多□药物的开发正在经历巨大的增长。 已经使用化学和生物学方法生成和修饰了□，新颖的设计和递送策略克服了它们固有的缺点并使该领域不断取得进展。 已经获得併研究了涵盖心臟代谢、免疫学、皮肤和肿瘤学等各种治疗领域的多种天然和修饰□。 随着 21 世纪的到来，多□药物开发进入了一个新时代，结构生物学、重组生物学以及新的合成和分析技术的进步显着加快了这一进程。 建立了包括多□药物发现、药物设计、多□合成、结构修饰和活性评价在内的先进的多□药物开发体系。

治疗性□是一类独特的药物，由氨基酸序列组成，通常分子量为 500-5000 Da。

市场动态

市场先驱们正致力于开发新颖和创新的□疗法，通过增强的生物相容性和强大的治疗功效为目标患者提供量身定制的解决方案。 癌症、心血管疾病和糖尿病患病率的增加预计将在预测期内推动□治疗市场的增长。

为了扩大产品组合，市场的主要参与者越来越多地采用联盟等有机增长战略，预计这将在预测期内推动市场增长。 例如，2023年1月，全球最大的製药公司礼来公司与全球医疗保健公司默克公司就多□靶向药物递送合作，收购生物製药公司PeptiDream，宣布合作。

这项研究的主要特点

• 本报告对全球□治疗市场进行了深入分析，展示了以 2022 年为基准年的预测期（2023 年至 2030 年）的市场规模和復合年增长率 (CAGR%) 的增长情况。
• 它揭示了各个细分市场的潜在收入机会，并描述了该市场具有吸引力的投资建议矩阵。
• 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 本文根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数，介绍了全球□治疗市场的主要参与者。
• 本次调查涵盖的主要公司：Teva Pharmaceutical Industries Ltd、Novo Nordisk A/S、OPKO Health, Inc.、Lilly、Hanmi Pharm.Co.、Sanofi、Circle Pharma、Pfizer Inc.、Novartis AG、PeptiDream Inc.。 , Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG。
• 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球□治疗市场报告迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球□治疗市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写

第二章市场范围

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 按产品类型划分的市场概况
  • 市场概况：按应用分类
  • 按给药途径划分的市场概况
  • 市场概况：按地区
• 连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场吸引力分析
  • 市场机会
• 产品发布
• 合併/收购/联合研究
• 监管准则和合规性
• 主要发展
• 害虫分析
• 技术概况
• 对 PORTER 的分析
• 价格分析 (2021)

第 4 章全球□治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

• 经济影响
• COVID-19 流行病学
• 对供需的影响

第 5 章全球□治疗市场，按产品类型，2017-2030

• 品牌□
• 通用□

第 6 章全球□治疗市场，按应用，2017-2030

• 癌症
• 心血管疾病
• 代谢综合征（代谢性疾病
• 呼吸系统疾病
• 感染
• 其他

第 7 章按给药途径划分的全球□治疗市场，2017-2030

• 口服给药
• 肠外给药
• 其他

第 8 章全球□治疗市场，按地区划分，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第9章竞争格局

• Teva Pharmaceutical Industries Ltd.
• Novo Nordisk A/S
• OPKO Health, Inc.
• Lilly
• Hanmi Pharm.Co.
• Sanofi
• Circle Pharma
• Pfizer Inc.
• Novartis AG
• PeptiDream Inc.
• Amgen Inc.
• AstraZeneca
• Bachem Holding AG
• CordenPharma International
• Ipsen Pharma
• Merck KGaA
• PolyPeptide Group
• Bayer AG

第 10 章

• 调查方法
• 关于出版商

Peptide drug development has grown immensely due to new manufacturing, modification, and analytical techniques. Peptides are generated and modified using both chemical and biological methods, along with new design and delivery strategies that overcomes the inherent drawbacks of peptide and enables continued progress in this field. A wide variety of natural and modified peptides have been obtained and studied covering multiple therapeutic area such as cardio metabolic, immunology and dermatology, oncology, etc. Peptide drug development entered a new era with the advent of the 21st century, since then advances in structural biology, recombinant biologics, and new synthetic and analytic technologies have significantly accelerated the process. A sophisticated system of peptide drug development has been established, including peptide drug discovery, drug design, peptide synthesis, structural modification, and activity evaluation.

Therapeutic peptides are a unique class of pharmaceuticals composed of an ordered series of amino acids, typically with molecular weights between 500 and 5000 Da.

Market Dynamics

Market players are developing novel and innovative peptide therapeutics to provide tailored solutions for target patients, by enhancing biocompatibility and potent therapeutic efficacy. Increasing prevalence of cancer, cardiovascular diseases, and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period.

Increasing adoption of organic growth strategies such as collaborations by key players in the market in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2023, Lilly, one of the world's largest pharmaceutical companies, and Merck, a global healthcare company, announced their partnership for peptide-targeted drug delivery, collaborating to acquire PeptiDream which is a biopharmaceutical company.

Key features of the study:

• This report provides in-depth analysis of the global peptide therapeutics market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global peptide therapeutics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health, Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide therapeutics market

Detailed Segmentation:

• Global Peptide Therapeutics Market, By Product Type:
  • Branded Peptide
  • Generic Peptide
• Global Peptide Therapeutics Market, By Application:
  • Cancer
  • Cardiovascular diseases
  • Metabolic diseases
  • Respiratory diseases
  • Infectious diseases
  • Others
• Global Peptide Therapeutics Market, By Route of Administration:
  • Oral Administration
  • Parenteral Administration
  • Others
• Global Peptide Therapeutics Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Teva Pharmaceutical Industries Ltd.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novo Nordisk A/S
  • OPKO Health, Inc.
  • Lilly
  • Hanmi Pharm.Co.
  • Sanofi
  • Circle Pharma
  • Pfizer Inc.
  • Novartis AG
  • PeptiDream Inc.
  • Amgen Inc.
  • AstraZeneca
  • Bachem Holding AG
  • CordenPharma International
  • Ipsen Pharma
  • Merck KGaA
  • PolyPeptide Group
  • Bayer AG

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis
• Technology Landscape
• PORTER's Analysis
• Pricing Analysis (2021)

4. Global Peptide Therapeutics Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Peptide Therapeutics Market, By Product Type, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Branded Peptide
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Generic Peptide
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Peptide Therapeutics Market, By Application, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Cardiovascular Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Metabolic Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Respiratory Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Infectious Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Peptide Therapeutics Market, By Route of Administration, 2017-2030, (US$ Million)

• Oral Administration
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Parenteral Administration
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Peptide Therapeutics Market, By Region, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novo Nordisk A/S
• OPKO Health, Inc.
• Lilly
• Hanmi Pharm.Co.
• Sanofi
• Circle Pharma
• Pfizer Inc.
• Novartis AG
• PeptiDream Inc.
• Amgen Inc.
• AstraZeneca
• Bachem Holding AG
• CordenPharma International
• Ipsen Pharma
• Merck KGaA
• PolyPeptide Group
• Bayer AG

10. Section

• Research Methodology
• About Us